Search

everythinglearnresearchcommunity

for

Search:↓

Ahmad's NPRT system accurately documents and predicts male pattern baldness.

Hospital staff have a higher rate of hair loss than the general population.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

Botulinum toxin type A is a safe and effective treatment for male pattern baldness.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

58% of men aged 30-50 have hair loss, with severity increasing with age.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

Scalp reduction can improve hair distribution in certain baldness cases but requires careful patient selection and understanding of facial structure.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

PRP combined with minoxidil is the most effective and safe treatment for male pattern baldness.

Baldness does not affect vitamin D levels in men.

Using a laser helmet with Minoxidil works better for male hair loss than Minoxidil alone, with no extra side effects.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

At least 87% of Indian men experience hair loss, with type II being most common and severity increasing with age.

The conclusion is that modifying scalp lifting surgery by cutting one occipital artery and making other changes reduces complications and improves outcomes for patients with severe hair loss.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Baldness is more common in Chinese men than women, increasing with age, and is influenced by genetics.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Hair follicles convert androgens, affecting hair loss patterns.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Microneedling with PRP is more effective and satisfying for male pattern hair loss than microneedling with minoxidil.